Detalles de la búsqueda
1.
Longitudinal associations of adherence to lifestyle recommendations and health-related quality of life in patients with non-muscle invasive bladder cancer.
Int J Cancer
; 152(10): 2032-2042, 2023 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36594579
2.
Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome.
Cancer Immunol Immunother
; 72(1): 137-149, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35771253
3.
The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients.
World J Urol
; 41(7): 1829-1835, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37195314
4.
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients.
Br J Cancer
; 127(11): 2043-2051, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36192490
5.
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
Int J Cancer
; 148(4): 981-987, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33006377
6.
Orthotopic urinary diversions after radical cystectomy for bladder cancer: lessons learned last decade.
Curr Opin Urol
; 31(6): 580-585, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34175877
7.
ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer.
World J Urol
; 37(1): 51-60, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30109483
8.
Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue.
Int J Hyperthermia
; 34(7): 988-993, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29191126
9.
Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
BJU Int
; 120(1): 12-24, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28220653
10.
Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.
Hum Mol Genet
; 23(20): 5545-57, 2014 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24861552
11.
Effects of hyperthermia in neutralising mechanisms of drug resistance in non-muscle-invasive bladder cancer.
Int J Hyperthermia
; 32(4): 434-45, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27098923
12.
Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.
World J Urol
; 33(10): 1411-7, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25491674
13.
Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer.
J Urol
; 192(3): 708-13, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24704017
14.
The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer.
World J Urol
; 32(3): 651-9, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24166285
15.
Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort.
Eur Urol Open Sci
; 59: 50-54, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38213646
16.
Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer.
Eur Urol Oncol
; 7(2): 282-291, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37673768
17.
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
Eur Urol
; 85(1): 17-31, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37858453
18.
Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System.
Nat Rev Urol
; 21(4): 243-251, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38036666
19.
The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b Study.
Eur Urol Open Sci
; 62: 8-15, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38585206
20.
Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 Clinical Trial.
Eur Urol Open Sci
; 60: 15-23, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38375344